Stock Market & Financial Investment News

News Breaks November 23, 2011 09:00 EDT PPHM theflyonthewall.com: Peregrine Pharma weakness creates buying opportunity, says Roth Capital Roth Capital has positive outlooks on Peregrine's two main drug candidates and the firm reiterates a $10 target and Buy rating on the shares. :theflyonthewall.com News For PPHM From The Last 14 Days Check below for free stories on PPHM the last two weeks. There are 2 items on the Fly with pertinent information. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2012 09:00 EDT PPHM theflyonthewall.com: Peregrine Pharmaceuticals target raised to $5 from $3.30 at Roth Capital Subscribe for More Information :theflyonthewall.com 07:36 EDT PPHM theflyonthewall.com: Peregrine announces positive top-line data from Bavituximab Phase II trial Subscribe for More Information :theflyonthewall.com